Eventide Asset Management - DESIGN THERAPEUTICS INC ownership

DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 51 filers reported holding DESIGN THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of DESIGN THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$3,942,000
-39.0%
281,569
-29.6%
0.08%
-16.8%
Q1 2022$6,460,000
-24.6%
400,0000.0%0.10%
-7.3%
Q4 2021$8,564,000
+45.7%
400,0000.0%0.11%
+41.6%
Q3 2021$5,876,000
-26.1%
400,0000.0%0.08%
-28.0%
Q2 2021$7,956,000
-33.5%
400,0000.0%0.11%
-39.5%
Q1 2021$11,960,000400,0000.18%
Other shareholders
DESIGN THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 5,626,476$90,868,00046.52%
Cormorant Asset Management, LP 5,156,994$83,285,0006.39%
Logos Global Management LP 2,797,501$45,180,0005.86%
EcoR1 Capital, LLC 2,371,445$38,299,0001.20%
RA Capital Management 2,186,636$35,314,0000.77%
Ghost Tree Capital, LLC 200,000$3,230,0000.70%
Avoro Capital Advisors LLC 2,222,222$35,889,0000.66%
Vivo Capital, LLC 476,589$7,697,0000.53%
Artal Group S.A. 400,000$6,460,0000.27%
Rock Springs Capital Management LP 345,597$5,581,0000.14%
View complete list of DESIGN THERAPEUTICS INC shareholders